Minerva Neurosciences, Inc. Operating Income
Minerva Neurosciences, Inc. (NERV) reported Operating Income of -$10.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Minerva Neurosciences, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$10.64M.
- Minerva Neurosciences, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$16.67M.
- Minerva Neurosciences, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$4.98M.
- Minerva Neurosciences, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$2.84M.
- Minerva Neurosciences, Inc. operating income (loss) for fiscal 2025 was -$15.10M.
- Minerva Neurosciences, Inc. operating income (loss) for fiscal 2024 was -$21.85M.
- Minerva Neurosciences, Inc. operating income (loss) for fiscal 2023 was -$23.12M.
- Minerva Neurosciences, Inc. operating income (loss) for fiscal 2022 was -$25.23M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$10.64M 10-Q · filed 2026-08-07 | -$27.31M 10-Q · filed 2026-08-07 | -$32.30M derived: sum of 3 quarters · filed 2026-08-07 | -$35.14M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$16.67M 10-Q · filed 2026-05-05 | -$21.65M derived: sum of 2 quarters · filed 2026-05-05 | -$24.50M derived: sum of 3 quarters · filed 2026-05-05 | -$27.87M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$7.83M derived: sum of 2 quarters · filed 2026-03-11 | -$11.20M derived: sum of 3 quarters · filed 2026-08-07 | -$15.10M 10-K · filed 2026-03-11 | |
| 2025-09-30 | -$2.84M 10-Q · filed 2025-11-05 | -$6.22M derived: sum of 2 quarters · filed 2026-08-07 | -$10.12M 10-Q · filed 2025-11-05 | -$14.64M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$3.37M 10-Q · filed 2026-08-07 | -$7.28M 10-Q · filed 2026-08-07 | -$11.80M derived: sum of 3 quarters · filed 2026-08-07 | -$16.17M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$3.90M 10-Q · filed 2026-05-05 | -$8.43M derived: sum of 2 quarters · filed 2026-05-05 | -$12.79M derived: sum of 3 quarters · filed 2026-05-05 | -$19.07M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$8.89M derived: sum of 2 quarters · filed 2026-03-11 | -$15.17M derived: sum of 3 quarters · filed 2026-03-11 | -$21.85M 10-K · filed 2026-03-11 | |
| 2024-09-30 | -$4.37M 10-Q · filed 2025-11-05 | -$10.64M derived: sum of 2 quarters · filed 2025-11-05 | -$17.33M 10-Q · filed 2025-11-05 | -$24.50M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$6.28M 10-Q · filed 2025-08-14 | -$12.96M 10-Q · filed 2025-08-14 | -$20.13M derived: sum of 3 quarters · filed 2025-08-14 | -$26.21M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$6.68M 10-Q · filed 2025-05-13 | -$13.85M derived: sum of 2 quarters · filed 2025-05-13 | -$19.93M derived: sum of 3 quarters · filed 2025-05-13 | -$24.45M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$13.25M derived: sum of 2 quarters · filed 2025-02-25 | -$17.77M derived: sum of 3 quarters · filed 2025-02-25 | -$23.12M 10-K · filed 2025-02-25 | |
| 2023-09-30 | -$6.08M 10-Q · filed 2024-11-05 | -$10.60M derived: sum of 2 quarters · filed 2024-11-05 | -$15.95M 10-Q · filed 2024-11-05 | -$21.02M derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | -$4.52M 10-Q · filed 2024-08-06 | -$9.87M 10-Q · filed 2024-08-06 | -$14.94M derived: sum of 3 quarters · filed 2024-08-06 | -$20.15M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | -$5.35M 10-Q · filed 2024-05-01 | -$10.42M derived: sum of 2 quarters · filed 2024-05-01 | -$15.63M derived: sum of 3 quarters · filed 2024-05-01 | -$22.59M derived: sum of 4 quarters · filed 2024-05-01 | |
| 2022-12-31 | -$5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$10.28M derived: sum of 2 quarters · filed 2024-02-22 | -$17.24M derived: sum of 3 quarters · filed 2024-02-22 | -$25.23M 10-K · filed 2024-02-22 | |
| 2022-09-30 | -$5.21M 10-Q · filed 2023-11-07 | -$12.17M derived: sum of 2 quarters · filed 2023-11-07 | -$20.16M 10-Q · filed 2023-11-07 | -$41.54M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$6.97M 10-Q · filed 2023-08-01 | -$14.95M 10-Q · filed 2023-08-01 | -$36.33M derived: sum of 3 quarters · filed 2023-08-01 | -$43.85M derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-03-31 | -$7.99M 10-Q · filed 2023-05-15 | -$29.37M derived: sum of 2 quarters · filed 2023-05-15 | -$36.88M derived: sum of 3 quarters · filed 2023-05-15 | -$45.85M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$21.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$28.89M derived: sum of 2 quarters · filed 2023-03-08 | -$37.86M derived: sum of 3 quarters · filed 2023-03-08 | -$45.37M 10-K · filed 2023-03-08 | |
| 2021-09-30 | -$7.52M 10-Q · filed 2022-11-09 | -$16.48M derived: sum of 2 quarters · filed 2022-11-09 | -$23.99M 10-Q · filed 2022-11-09 | -$31.29M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$8.96M 10-Q · filed 2022-08-09 | -$16.47M 10-Q · filed 2022-08-09 | -$23.77M derived: sum of 3 quarters · filed 2022-08-09 | -$31.86M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | -$7.51M 10-Q · filed 2022-05-04 | -$14.81M derived: sum of 2 quarters · filed 2022-05-04 | -$22.90M derived: sum of 3 quarters · filed 2022-05-04 | $6.61M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | -$7.30M 10-K · filed 2021-03-08 | -$15.39M derived: sum of 2 quarters · filed 2021-11-08 | $14.12M derived: sum of 3 quarters · filed 2021-11-08 | $1.85M 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$8.09M 10-Q · filed 2021-11-08 | $21.42M derived: sum of 2 quarters · filed 2021-11-08 | $9.15M 10-Q · filed 2021-11-08 | -$23.22M derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-06-30 | $29.51M 10-Q · filed 2021-08-02 | $17.24M 10-Q · filed 2021-08-02 | -$15.13M derived: sum of 3 quarters · filed 2021-08-02 | -$29.41M derived: sum of 4 quarters · filed 2021-08-02 | |
| 2020-03-31 | -$12.27M 10-Q · filed 2021-05-12 | -$44.64M derived: sum of 2 quarters · filed 2021-05-12 | -$58.92M derived: sum of 3 quarters · filed 2021-05-12 | -$71.82M derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$32.37M 10-K · filed 2021-03-08 | -$46.65M derived: sum of 2 quarters · filed 2021-03-08 | -$59.55M derived: sum of 3 quarters · filed 2021-03-08 | -$75.87M 10-K · filed 2021-03-08 | |
| 2019-09-30 | -$14.28M 10-K · filed 2021-03-08 | -$14.28M 10-Q · filed 2019-11-04 | -$27.19M derived: sum of 2 quarters · filed 2021-03-08 | -$43.50M 10-Q · filed 2020-11-02 | -$57.13M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | -$12.90M 10-K · filed 2021-03-08 | -$12.90M 10-Q · filed 2019-08-05 | -$29.22M 10-Q · filed 2020-08-03 | -$42.84M derived: sum of 3 quarters · filed 2021-03-08 | -$55.27M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | -$16.31M 10-K · filed 2021-03-08 | -$16.31M 10-Q · filed 2019-05-06 | -$29.94M derived: sum of 2 quarters · filed 2021-03-08 | -$42.36M derived: sum of 3 quarters · filed 2021-03-08 | -$55.30M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | -$13.63M 10-K · filed 2020-03-09 | -$26.05M derived: sum of 2 quarters · filed 2020-03-09 | -$38.99M derived: sum of 3 quarters · filed 2020-03-09 | -$51.73M 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$12.42M 10-K · filed 2020-03-09 | -$12.42M 10-Q · filed 2018-11-05 | -$25.36M derived: sum of 2 quarters · filed 2020-03-09 | -$38.10M 10-Q · filed 2019-11-04 | -$47.63M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | -$12.94M 10-K · filed 2020-03-09 | -$12.93M 10-Q · filed 2018-08-02 | -$25.68M 10-Q · filed 2019-08-05 | -$35.21M derived: sum of 3 quarters · filed 2020-03-09 | -$46.62M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | -$12.74M 10-K · filed 2020-03-09 | -$12.74M 10-Q · filed 2018-05-03 | -$22.28M derived: sum of 2 quarters · filed 2020-03-09 | -$33.68M derived: sum of 3 quarters · filed 2020-03-09 | -$43.43M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | -$9.53M 10-K · filed 2019-03-12 | -$20.94M derived: sum of 2 quarters · filed 2019-03-12 | -$30.68M derived: sum of 3 quarters · filed 2019-03-12 | -$41.17M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$11.41M 10-K · filed 2019-03-12 | -$11.41M 10-Q · filed 2017-11-06 | -$21.15M derived: sum of 2 quarters · filed 2019-03-12 | -$31.64M 10-Q · filed 2018-11-05 | -$40.88M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$9.75M 10-K · filed 2019-03-12 | -$9.75M 10-Q · filed 2017-08-03 | -$20.23M 10-Q · filed 2018-08-02 | -$29.47M derived: sum of 3 quarters · filed 2019-03-12 | -$37.70M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$10.48M 10-K · filed 2019-03-12 | -$10.49M 10-Q · filed 2017-05-04 | -$19.72M derived: sum of 2 quarters · filed 2019-03-12 | -$27.95M derived: sum of 3 quarters · filed 2019-03-12 | -$32.92M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$9.24M 10-K · filed 2018-03-12 | -$17.47M derived: sum of 2 quarters · filed 2018-03-12 | -$22.43M derived: sum of 3 quarters · filed 2018-03-12 | -$30.19M 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$8.23M 10-K · filed 2018-03-12 | -$8.23M 10-Q · filed 2016-11-03 | -$13.20M derived: sum of 2 quarters · filed 2018-03-12 | -$20.95M 10-Q · filed 2017-11-06 | -$29.15M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$4.96M 10-K · filed 2018-03-12 | -$4.96M 10-Q · filed 2016-08-04 | -$12.72M 10-Q · filed 2017-08-03 | -$20.92M derived: sum of 3 quarters · filed 2018-03-12 | -$26.62M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$7.76M 10-K · filed 2018-03-12 | -$7.76M 10-Q · filed 2016-05-03 | -$15.95M derived: sum of 2 quarters · filed 2018-03-12 | -$21.66M derived: sum of 3 quarters · filed 2018-03-12 | -$27.99M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$8.19M 10-K · filed 2018-03-12 | -$13.90M derived: sum of 2 quarters · filed 2018-03-12 | -$20.23M derived: sum of 3 quarters · filed 2018-03-12 | -$26.11M 10-K · filed 2018-03-12 | |
| 2015-09-30 | -$5.71M 10-K · filed 2018-03-12 | -$5.70M 10-Q · filed 2015-11-05 | -$12.04M derived: sum of 2 quarters · filed 2018-03-12 | -$17.92M 10-Q · filed 2016-11-03 | -$25.36M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-06-30 | -$6.33M 10-K · filed 2018-03-12 | -$6.33M 10-Q · filed 2015-08-05 | -$12.21M 10-Q · filed 2016-08-04 | -$19.66M derived: sum of 3 quarters · filed 2018-03-12 | -$46.81M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-03-31 | -$5.88M 10-K · filed 2018-03-12 | -$5.88M 10-Q · filed 2015-05-07 | -$13.32M derived: sum of 2 quarters · filed 2018-03-12 | -$40.48M derived: sum of 3 quarters · filed 2018-03-12 | -$58.13M derived: sum of 4 quarters · filed 2018-03-12 |
| 2014-12-31 | -$7.45M 10-K · filed 2017-03-13 | -$34.60M derived: sum of 2 quarters · filed 2017-03-13 | -$52.25M derived: sum of 3 quarters · filed 2017-03-13 | -$54.87M 10-K · filed 2017-03-13 | |
| 2014-09-30 | -$27.15M 10-K · filed 2017-03-13 | -$27.15M 10-Q · filed 2014-11-06 | -$44.80M derived: sum of 2 quarters · filed 2017-03-13 | -$47.42M 10-Q · filed 2015-11-05 | -$49.47M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-06-30 | -$17.65M 10-K · filed 2017-03-13 | -$17.65M 10-Q · filed 2014-08-07 | -$20.27M 10-Q · filed 2015-08-05 | -$22.32M derived: sum of 3 quarters · filed 2017-03-13 | -$22.80M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-03-31 | -$2.62M 10-K · filed 2017-03-13 | -$4.67M derived: sum of 2 quarters · filed 2017-03-13 | -$5.15M derived: sum of 3 quarters · filed 2017-03-13 | -$5.53M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2013-12-31 | -$2.04M 10-K · filed 2015-03-26 | -$2.52M derived: sum of 2 quarters · filed 2015-03-26 | -$2.90M derived: sum of 3 quarters · filed 2015-03-26 | -$3.17M 10-K · filed 2015-03-26 | |
| 2013-09-30 | -$482.00K 10-K · filed 2015-03-26 | -$482.47K 10-Q · filed 2014-11-06 | -$861.00K derived: sum of 2 quarters · filed 2015-03-26 | -$1.13M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | -$379.00K 10-K · filed 2015-03-26 | -$378.79K 10-Q · filed 2014-08-07 | -$650.12K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$271.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |